Global Chronic Constipation Treatment Drugs Market Growth 2026-2032
The global Chronic Constipation Treatment Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Chronic Constipation Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Chronic Constipation Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Chronic Constipation Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Chronic Constipation Treatment Drugs players cover Pfizer, Ardelyx, Norgine, Takeda Pharmaceuticals, Ironwood Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Chronic Constipation Treatment Drugs Industry Forecast? looks at past sales and reviews total world Chronic Constipation Treatment Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Chronic Constipation Treatment Drugs sales for 2026 through 2032. With Chronic Constipation Treatment Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Constipation Treatment Drugs industry.
This Insight Report provides a comprehensive analysis of the global Chronic Constipation Treatment Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Constipation Treatment Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Chronic Constipation Treatment Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Constipation Treatment Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Constipation Treatment Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Constipation Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Chronic Constipation Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Chronic Constipation Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Chronic Constipation Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Chronic Constipation Treatment Drugs players cover Pfizer, Ardelyx, Norgine, Takeda Pharmaceuticals, Ironwood Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Chronic Constipation Treatment Drugs Industry Forecast? looks at past sales and reviews total world Chronic Constipation Treatment Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Chronic Constipation Treatment Drugs sales for 2026 through 2032. With Chronic Constipation Treatment Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Constipation Treatment Drugs industry.
This Insight Report provides a comprehensive analysis of the global Chronic Constipation Treatment Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Constipation Treatment Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Chronic Constipation Treatment Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Constipation Treatment Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Constipation Treatment Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Constipation Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Serotonin-4 (5-Ht4) Receptor Agonist
- Guanylate Cyclase-C Agonist
- Laxatives
- Stimulants
- Others
- Hospitals
- Homecare
- Specialty Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Ardelyx
- Norgine
- Takeda Pharmaceuticals
- Ironwood Pharmaceuticals
- Synergy Pharmaceuticals
- Salix Pharmaceuticals
- Shire Pharmaceuticals
- Allergan
- Renexxion
- Sucampo Pharmaceuticals
- Shionogi
- Teva Pharmaceuticals
- RedHill Biopharma
- Ferring Pharmaceuticals
- Theravance Biopharma
- Progenity Inc.
- Synthetic Biologics
- Progenics Pharmaceuticals
- What is the 10-year outlook for the global Chronic Constipation Treatment Drugs market?
- What factors are driving Chronic Constipation Treatment Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Chronic Constipation Treatment Drugs market opportunities vary by end market size?
- How does Chronic Constipation Treatment Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Constipation Treatment Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Chronic Constipation Treatment Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Chronic Constipation Treatment Drugs by Country/Region, 2021, 2025 & 2032
2.2 Chronic Constipation Treatment Drugs Segment by Type
2.2.1 Serotonin-4 (5-Ht4) Receptor Agonist
2.2.2 Guanylate Cyclase-C Agonist
2.2.3 Laxatives
2.2.4 Stimulants
2.2.5 Others
2.2.6 Chronic Constipation Treatment Drugs Sales by Type
2.2.6.1 Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global Chronic Constipation Treatment Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Chronic Constipation Treatment Drugs Sale Price by Type (2021-2026)
2.3 Chronic Constipation Treatment Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Homecare
2.3.3 Specialty Clinics
2.3.4 Others
2.3.5 Chronic Constipation Treatment Drugs Sales by Application
2.3.5.1 Global Chronic Constipation Treatment Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Chronic Constipation Treatment Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Chronic Constipation Treatment Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Chronic Constipation Treatment Drugs Breakdown Data by Company
3.1.1 Global Chronic Constipation Treatment Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Chronic Constipation Treatment Drugs Sales Market Share by Company (2021-2026)
3.2 Global Chronic Constipation Treatment Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Chronic Constipation Treatment Drugs Revenue by Company (2021-2026)
3.2.2 Global Chronic Constipation Treatment Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Chronic Constipation Treatment Drugs Sale Price by Company
3.4 Key Manufacturers Chronic Constipation Treatment Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Constipation Treatment Drugs Product Location Distribution
3.4.2 Players Chronic Constipation Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHRONIC CONSTIPATION TREATMENT DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Chronic Constipation Treatment Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Chronic Constipation Treatment Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Chronic Constipation Treatment Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Chronic Constipation Treatment Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Chronic Constipation Treatment Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Chronic Constipation Treatment Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Chronic Constipation Treatment Drugs Sales Growth
4.4 APAC Chronic Constipation Treatment Drugs Sales Growth
4.5 Europe Chronic Constipation Treatment Drugs Sales Growth
4.6 Middle East & Africa Chronic Constipation Treatment Drugs Sales Growth
5 AMERICAS
5.1 Americas Chronic Constipation Treatment Drugs Sales by Country
5.1.1 Americas Chronic Constipation Treatment Drugs Sales by Country (2021-2026)
5.1.2 Americas Chronic Constipation Treatment Drugs Revenue by Country (2021-2026)
5.2 Americas Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
5.3 Americas Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Constipation Treatment Drugs Sales by Region
6.1.1 APAC Chronic Constipation Treatment Drugs Sales by Region (2021-2026)
6.1.2 APAC Chronic Constipation Treatment Drugs Revenue by Region (2021-2026)
6.2 APAC Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
6.3 APAC Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Constipation Treatment Drugs by Country
7.1.1 Europe Chronic Constipation Treatment Drugs Sales by Country (2021-2026)
7.1.2 Europe Chronic Constipation Treatment Drugs Revenue by Country (2021-2026)
7.2 Europe Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
7.3 Europe Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Constipation Treatment Drugs by Country
8.1.1 Middle East & Africa Chronic Constipation Treatment Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Chronic Constipation Treatment Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Constipation Treatment Drugs
10.3 Manufacturing Process Analysis of Chronic Constipation Treatment Drugs
10.4 Industry Chain Structure of Chronic Constipation Treatment Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Constipation Treatment Drugs Distributors
11.3 Chronic Constipation Treatment Drugs Customer
12 WORLD FORECAST REVIEW FOR CHRONIC CONSTIPATION TREATMENT DRUGS BY GEOGRAPHIC REGION
12.1 Global Chronic Constipation Treatment Drugs Market Size Forecast by Region
12.1.1 Global Chronic Constipation Treatment Drugs Forecast by Region (2027-2032)
12.1.2 Global Chronic Constipation Treatment Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Chronic Constipation Treatment Drugs Forecast by Type (2027-2032)
12.7 Global Chronic Constipation Treatment Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.1.3 Pfizer Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Ardelyx
13.2.1 Ardelyx Company Information
13.2.2 Ardelyx Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.2.3 Ardelyx Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ardelyx Main Business Overview
13.2.5 Ardelyx Latest Developments
13.3 Norgine
13.3.1 Norgine Company Information
13.3.2 Norgine Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.3.3 Norgine Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Norgine Main Business Overview
13.3.5 Norgine Latest Developments
13.4 Takeda Pharmaceuticals
13.4.1 Takeda Pharmaceuticals Company Information
13.4.2 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.4.3 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Takeda Pharmaceuticals Main Business Overview
13.4.5 Takeda Pharmaceuticals Latest Developments
13.5 Ironwood Pharmaceuticals
13.5.1 Ironwood Pharmaceuticals Company Information
13.5.2 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.5.3 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ironwood Pharmaceuticals Main Business Overview
13.5.5 Ironwood Pharmaceuticals Latest Developments
13.6 Synergy Pharmaceuticals
13.6.1 Synergy Pharmaceuticals Company Information
13.6.2 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.6.3 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Synergy Pharmaceuticals Main Business Overview
13.6.5 Synergy Pharmaceuticals Latest Developments
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Information
13.7.2 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.7.3 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Salix Pharmaceuticals Main Business Overview
13.7.5 Salix Pharmaceuticals Latest Developments
13.8 Shire Pharmaceuticals
13.8.1 Shire Pharmaceuticals Company Information
13.8.2 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.8.3 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shire Pharmaceuticals Main Business Overview
13.8.5 Shire Pharmaceuticals Latest Developments
13.9 Allergan
13.9.1 Allergan Company Information
13.9.2 Allergan Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.9.3 Allergan Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Allergan Main Business Overview
13.9.5 Allergan Latest Developments
13.10 Renexxion
13.10.1 Renexxion Company Information
13.10.2 Renexxion Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.10.3 Renexxion Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Renexxion Main Business Overview
13.10.5 Renexxion Latest Developments
13.11 Sucampo Pharmaceuticals
13.11.1 Sucampo Pharmaceuticals Company Information
13.11.2 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.11.3 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sucampo Pharmaceuticals Main Business Overview
13.11.5 Sucampo Pharmaceuticals Latest Developments
13.12 Shionogi
13.12.1 Shionogi Company Information
13.12.2 Shionogi Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.12.3 Shionogi Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shionogi Main Business Overview
13.12.5 Shionogi Latest Developments
13.13 Teva Pharmaceuticals
13.13.1 Teva Pharmaceuticals Company Information
13.13.2 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.13.3 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Teva Pharmaceuticals Main Business Overview
13.13.5 Teva Pharmaceuticals Latest Developments
13.14 RedHill Biopharma
13.14.1 RedHill Biopharma Company Information
13.14.2 RedHill Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.14.3 RedHill Biopharma Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 RedHill Biopharma Main Business Overview
13.14.5 RedHill Biopharma Latest Developments
13.15 Ferring Pharmaceuticals
13.15.1 Ferring Pharmaceuticals Company Information
13.15.2 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.15.3 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Ferring Pharmaceuticals Main Business Overview
13.15.5 Ferring Pharmaceuticals Latest Developments
13.16 Theravance Biopharma
13.16.1 Theravance Biopharma Company Information
13.16.2 Theravance Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.16.3 Theravance Biopharma Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Theravance Biopharma Main Business Overview
13.16.5 Theravance Biopharma Latest Developments
13.17 Progenity Inc.
13.17.1 Progenity Inc. Company Information
13.17.2 Progenity Inc. Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.17.3 Progenity Inc. Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Progenity Inc. Main Business Overview
13.17.5 Progenity Inc. Latest Developments
13.18 Synthetic Biologics
13.18.1 Synthetic Biologics Company Information
13.18.2 Synthetic Biologics Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.18.3 Synthetic Biologics Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Synthetic Biologics Main Business Overview
13.18.5 Synthetic Biologics Latest Developments
13.19 Progenics Pharmaceuticals
13.19.1 Progenics Pharmaceuticals Company Information
13.19.2 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.19.3 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Progenics Pharmaceuticals Main Business Overview
13.19.5 Progenics Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Constipation Treatment Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Chronic Constipation Treatment Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Chronic Constipation Treatment Drugs by Country/Region, 2021, 2025 & 2032
2.2 Chronic Constipation Treatment Drugs Segment by Type
2.2.1 Serotonin-4 (5-Ht4) Receptor Agonist
2.2.2 Guanylate Cyclase-C Agonist
2.2.3 Laxatives
2.2.4 Stimulants
2.2.5 Others
2.2.6 Chronic Constipation Treatment Drugs Sales by Type
2.2.6.1 Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global Chronic Constipation Treatment Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Chronic Constipation Treatment Drugs Sale Price by Type (2021-2026)
2.3 Chronic Constipation Treatment Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Homecare
2.3.3 Specialty Clinics
2.3.4 Others
2.3.5 Chronic Constipation Treatment Drugs Sales by Application
2.3.5.1 Global Chronic Constipation Treatment Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Chronic Constipation Treatment Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Chronic Constipation Treatment Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Chronic Constipation Treatment Drugs Breakdown Data by Company
3.1.1 Global Chronic Constipation Treatment Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Chronic Constipation Treatment Drugs Sales Market Share by Company (2021-2026)
3.2 Global Chronic Constipation Treatment Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Chronic Constipation Treatment Drugs Revenue by Company (2021-2026)
3.2.2 Global Chronic Constipation Treatment Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Chronic Constipation Treatment Drugs Sale Price by Company
3.4 Key Manufacturers Chronic Constipation Treatment Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Constipation Treatment Drugs Product Location Distribution
3.4.2 Players Chronic Constipation Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHRONIC CONSTIPATION TREATMENT DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Chronic Constipation Treatment Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Chronic Constipation Treatment Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Chronic Constipation Treatment Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Chronic Constipation Treatment Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Chronic Constipation Treatment Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Chronic Constipation Treatment Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Chronic Constipation Treatment Drugs Sales Growth
4.4 APAC Chronic Constipation Treatment Drugs Sales Growth
4.5 Europe Chronic Constipation Treatment Drugs Sales Growth
4.6 Middle East & Africa Chronic Constipation Treatment Drugs Sales Growth
5 AMERICAS
5.1 Americas Chronic Constipation Treatment Drugs Sales by Country
5.1.1 Americas Chronic Constipation Treatment Drugs Sales by Country (2021-2026)
5.1.2 Americas Chronic Constipation Treatment Drugs Revenue by Country (2021-2026)
5.2 Americas Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
5.3 Americas Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Constipation Treatment Drugs Sales by Region
6.1.1 APAC Chronic Constipation Treatment Drugs Sales by Region (2021-2026)
6.1.2 APAC Chronic Constipation Treatment Drugs Revenue by Region (2021-2026)
6.2 APAC Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
6.3 APAC Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Constipation Treatment Drugs by Country
7.1.1 Europe Chronic Constipation Treatment Drugs Sales by Country (2021-2026)
7.1.2 Europe Chronic Constipation Treatment Drugs Revenue by Country (2021-2026)
7.2 Europe Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
7.3 Europe Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Constipation Treatment Drugs by Country
8.1.1 Middle East & Africa Chronic Constipation Treatment Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Chronic Constipation Treatment Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Chronic Constipation Treatment Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Chronic Constipation Treatment Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Constipation Treatment Drugs
10.3 Manufacturing Process Analysis of Chronic Constipation Treatment Drugs
10.4 Industry Chain Structure of Chronic Constipation Treatment Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Constipation Treatment Drugs Distributors
11.3 Chronic Constipation Treatment Drugs Customer
12 WORLD FORECAST REVIEW FOR CHRONIC CONSTIPATION TREATMENT DRUGS BY GEOGRAPHIC REGION
12.1 Global Chronic Constipation Treatment Drugs Market Size Forecast by Region
12.1.1 Global Chronic Constipation Treatment Drugs Forecast by Region (2027-2032)
12.1.2 Global Chronic Constipation Treatment Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Chronic Constipation Treatment Drugs Forecast by Type (2027-2032)
12.7 Global Chronic Constipation Treatment Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.1.3 Pfizer Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Ardelyx
13.2.1 Ardelyx Company Information
13.2.2 Ardelyx Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.2.3 Ardelyx Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ardelyx Main Business Overview
13.2.5 Ardelyx Latest Developments
13.3 Norgine
13.3.1 Norgine Company Information
13.3.2 Norgine Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.3.3 Norgine Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Norgine Main Business Overview
13.3.5 Norgine Latest Developments
13.4 Takeda Pharmaceuticals
13.4.1 Takeda Pharmaceuticals Company Information
13.4.2 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.4.3 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Takeda Pharmaceuticals Main Business Overview
13.4.5 Takeda Pharmaceuticals Latest Developments
13.5 Ironwood Pharmaceuticals
13.5.1 Ironwood Pharmaceuticals Company Information
13.5.2 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.5.3 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ironwood Pharmaceuticals Main Business Overview
13.5.5 Ironwood Pharmaceuticals Latest Developments
13.6 Synergy Pharmaceuticals
13.6.1 Synergy Pharmaceuticals Company Information
13.6.2 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.6.3 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Synergy Pharmaceuticals Main Business Overview
13.6.5 Synergy Pharmaceuticals Latest Developments
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Information
13.7.2 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.7.3 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Salix Pharmaceuticals Main Business Overview
13.7.5 Salix Pharmaceuticals Latest Developments
13.8 Shire Pharmaceuticals
13.8.1 Shire Pharmaceuticals Company Information
13.8.2 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.8.3 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shire Pharmaceuticals Main Business Overview
13.8.5 Shire Pharmaceuticals Latest Developments
13.9 Allergan
13.9.1 Allergan Company Information
13.9.2 Allergan Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.9.3 Allergan Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Allergan Main Business Overview
13.9.5 Allergan Latest Developments
13.10 Renexxion
13.10.1 Renexxion Company Information
13.10.2 Renexxion Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.10.3 Renexxion Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Renexxion Main Business Overview
13.10.5 Renexxion Latest Developments
13.11 Sucampo Pharmaceuticals
13.11.1 Sucampo Pharmaceuticals Company Information
13.11.2 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.11.3 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sucampo Pharmaceuticals Main Business Overview
13.11.5 Sucampo Pharmaceuticals Latest Developments
13.12 Shionogi
13.12.1 Shionogi Company Information
13.12.2 Shionogi Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.12.3 Shionogi Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shionogi Main Business Overview
13.12.5 Shionogi Latest Developments
13.13 Teva Pharmaceuticals
13.13.1 Teva Pharmaceuticals Company Information
13.13.2 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.13.3 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Teva Pharmaceuticals Main Business Overview
13.13.5 Teva Pharmaceuticals Latest Developments
13.14 RedHill Biopharma
13.14.1 RedHill Biopharma Company Information
13.14.2 RedHill Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.14.3 RedHill Biopharma Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 RedHill Biopharma Main Business Overview
13.14.5 RedHill Biopharma Latest Developments
13.15 Ferring Pharmaceuticals
13.15.1 Ferring Pharmaceuticals Company Information
13.15.2 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.15.3 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Ferring Pharmaceuticals Main Business Overview
13.15.5 Ferring Pharmaceuticals Latest Developments
13.16 Theravance Biopharma
13.16.1 Theravance Biopharma Company Information
13.16.2 Theravance Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.16.3 Theravance Biopharma Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Theravance Biopharma Main Business Overview
13.16.5 Theravance Biopharma Latest Developments
13.17 Progenity Inc.
13.17.1 Progenity Inc. Company Information
13.17.2 Progenity Inc. Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.17.3 Progenity Inc. Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Progenity Inc. Main Business Overview
13.17.5 Progenity Inc. Latest Developments
13.18 Synthetic Biologics
13.18.1 Synthetic Biologics Company Information
13.18.2 Synthetic Biologics Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.18.3 Synthetic Biologics Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Synthetic Biologics Main Business Overview
13.18.5 Synthetic Biologics Latest Developments
13.19 Progenics Pharmaceuticals
13.19.1 Progenics Pharmaceuticals Company Information
13.19.2 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
13.19.3 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Progenics Pharmaceuticals Main Business Overview
13.19.5 Progenics Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chronic Constipation Treatment Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Chronic Constipation Treatment Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Serotonin-4 (5-Ht4) Receptor Agonist
Table 4. Major Players of Guanylate Cyclase-C Agonist
Table 5. Major Players of Laxatives
Table 6. Major Players of Stimulants
Table 7. Major Players of Others
Table 8. Global Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Table 10. Global Chronic Constipation Treatment Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global Chronic Constipation Treatment Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Chronic Constipation Treatment Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global Chronic Constipation Treatment Drugs Sale Market Share by Application (2021-2026)
Table 15. Global Chronic Constipation Treatment Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global Chronic Constipation Treatment Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Chronic Constipation Treatment Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global Chronic Constipation Treatment Drugs Sales Market Share by Company (2021-2026)
Table 20. Global Chronic Constipation Treatment Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Chronic Constipation Treatment Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global Chronic Constipation Treatment Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Chronic Constipation Treatment Drugs Producing Area Distribution and Sales Area
Table 24. Players Chronic Constipation Treatment Drugs Products Offered
Table 25. Chronic Constipation Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Chronic Constipation Treatment Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Chronic Constipation Treatment Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global Chronic Constipation Treatment Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Chronic Constipation Treatment Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Chronic Constipation Treatment Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Chronic Constipation Treatment Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global Chronic Constipation Treatment Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Chronic Constipation Treatment Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Chronic Constipation Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas Chronic Constipation Treatment Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas Chronic Constipation Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC Chronic Constipation Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC Chronic Constipation Treatment Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC Chronic Constipation Treatment Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe Chronic Constipation Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe Chronic Constipation Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Chronic Constipation Treatment Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Chronic Constipation Treatment Drugs
Table 55. Key Market Challenges & Risks of Chronic Constipation Treatment Drugs
Table 56. Key Industry Trends of Chronic Constipation Treatment Drugs
Table 57. Chronic Constipation Treatment Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Chronic Constipation Treatment Drugs Distributors List
Table 60. Chronic Constipation Treatment Drugs Customer List
Table 61. Global Chronic Constipation Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Chronic Constipation Treatment Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Chronic Constipation Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Chronic Constipation Treatment Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Chronic Constipation Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Chronic Constipation Treatment Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Chronic Constipation Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Chronic Constipation Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Chronic Constipation Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Chronic Constipation Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Chronic Constipation Treatment Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Chronic Constipation Treatment Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Chronic Constipation Treatment Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Chronic Constipation Treatment Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 77. Pfizer Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Ardelyx Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Ardelyx Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 82. Ardelyx Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Ardelyx Main Business
Table 84. Ardelyx Latest Developments
Table 85. Norgine Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Norgine Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 87. Norgine Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Norgine Main Business
Table 89. Norgine Latest Developments
Table 90. Takeda Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 92. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Takeda Pharmaceuticals Main Business
Table 94. Takeda Pharmaceuticals Latest Developments
Table 95. Ironwood Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 97. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Ironwood Pharmaceuticals Main Business
Table 99. Ironwood Pharmaceuticals Latest Developments
Table 100. Synergy Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 102. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Synergy Pharmaceuticals Main Business
Table 104. Synergy Pharmaceuticals Latest Developments
Table 105. Salix Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 107. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Salix Pharmaceuticals Main Business
Table 109. Salix Pharmaceuticals Latest Developments
Table 110. Shire Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 112. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Shire Pharmaceuticals Main Business
Table 114. Shire Pharmaceuticals Latest Developments
Table 115. Allergan Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Allergan Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 117. Allergan Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Allergan Main Business
Table 119. Allergan Latest Developments
Table 120. Renexxion Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Renexxion Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 122. Renexxion Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Renexxion Main Business
Table 124. Renexxion Latest Developments
Table 125. Sucampo Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 127. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Sucampo Pharmaceuticals Main Business
Table 129. Sucampo Pharmaceuticals Latest Developments
Table 130. Shionogi Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Shionogi Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 132. Shionogi Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Shionogi Main Business
Table 134. Shionogi Latest Developments
Table 135. Teva Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 137. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Teva Pharmaceuticals Main Business
Table 139. Teva Pharmaceuticals Latest Developments
Table 140. RedHill Biopharma Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. RedHill Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 142. RedHill Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. RedHill Biopharma Main Business
Table 144. RedHill Biopharma Latest Developments
Table 145. Ferring Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 147. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Ferring Pharmaceuticals Main Business
Table 149. Ferring Pharmaceuticals Latest Developments
Table 150. Theravance Biopharma Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Theravance Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 152. Theravance Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Theravance Biopharma Main Business
Table 154. Theravance Biopharma Latest Developments
Table 155. Progenity Inc. Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Progenity Inc. Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 157. Progenity Inc. Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Progenity Inc. Main Business
Table 159. Progenity Inc. Latest Developments
Table 160. Synthetic Biologics Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Synthetic Biologics Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 162. Synthetic Biologics Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Synthetic Biologics Main Business
Table 164. Synthetic Biologics Latest Developments
Table 165. Progenics Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 167. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Progenics Pharmaceuticals Main Business
Table 169. Progenics Pharmaceuticals Latest Developments
Table 1. Chronic Constipation Treatment Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Chronic Constipation Treatment Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Serotonin-4 (5-Ht4) Receptor Agonist
Table 4. Major Players of Guanylate Cyclase-C Agonist
Table 5. Major Players of Laxatives
Table 6. Major Players of Stimulants
Table 7. Major Players of Others
Table 8. Global Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Table 10. Global Chronic Constipation Treatment Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global Chronic Constipation Treatment Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Chronic Constipation Treatment Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global Chronic Constipation Treatment Drugs Sale Market Share by Application (2021-2026)
Table 15. Global Chronic Constipation Treatment Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global Chronic Constipation Treatment Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Chronic Constipation Treatment Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global Chronic Constipation Treatment Drugs Sales Market Share by Company (2021-2026)
Table 20. Global Chronic Constipation Treatment Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Chronic Constipation Treatment Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global Chronic Constipation Treatment Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Chronic Constipation Treatment Drugs Producing Area Distribution and Sales Area
Table 24. Players Chronic Constipation Treatment Drugs Products Offered
Table 25. Chronic Constipation Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Chronic Constipation Treatment Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Chronic Constipation Treatment Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global Chronic Constipation Treatment Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Chronic Constipation Treatment Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Chronic Constipation Treatment Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Chronic Constipation Treatment Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global Chronic Constipation Treatment Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Chronic Constipation Treatment Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Chronic Constipation Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas Chronic Constipation Treatment Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas Chronic Constipation Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC Chronic Constipation Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC Chronic Constipation Treatment Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC Chronic Constipation Treatment Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe Chronic Constipation Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe Chronic Constipation Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Chronic Constipation Treatment Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Chronic Constipation Treatment Drugs
Table 55. Key Market Challenges & Risks of Chronic Constipation Treatment Drugs
Table 56. Key Industry Trends of Chronic Constipation Treatment Drugs
Table 57. Chronic Constipation Treatment Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Chronic Constipation Treatment Drugs Distributors List
Table 60. Chronic Constipation Treatment Drugs Customer List
Table 61. Global Chronic Constipation Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Chronic Constipation Treatment Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Chronic Constipation Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Chronic Constipation Treatment Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Chronic Constipation Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Chronic Constipation Treatment Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Chronic Constipation Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Chronic Constipation Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Chronic Constipation Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Chronic Constipation Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Chronic Constipation Treatment Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Chronic Constipation Treatment Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Chronic Constipation Treatment Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Chronic Constipation Treatment Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 77. Pfizer Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Ardelyx Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Ardelyx Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 82. Ardelyx Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Ardelyx Main Business
Table 84. Ardelyx Latest Developments
Table 85. Norgine Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Norgine Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 87. Norgine Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Norgine Main Business
Table 89. Norgine Latest Developments
Table 90. Takeda Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 92. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Takeda Pharmaceuticals Main Business
Table 94. Takeda Pharmaceuticals Latest Developments
Table 95. Ironwood Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 97. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Ironwood Pharmaceuticals Main Business
Table 99. Ironwood Pharmaceuticals Latest Developments
Table 100. Synergy Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 102. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Synergy Pharmaceuticals Main Business
Table 104. Synergy Pharmaceuticals Latest Developments
Table 105. Salix Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 107. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Salix Pharmaceuticals Main Business
Table 109. Salix Pharmaceuticals Latest Developments
Table 110. Shire Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 112. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Shire Pharmaceuticals Main Business
Table 114. Shire Pharmaceuticals Latest Developments
Table 115. Allergan Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Allergan Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 117. Allergan Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Allergan Main Business
Table 119. Allergan Latest Developments
Table 120. Renexxion Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Renexxion Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 122. Renexxion Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Renexxion Main Business
Table 124. Renexxion Latest Developments
Table 125. Sucampo Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 127. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Sucampo Pharmaceuticals Main Business
Table 129. Sucampo Pharmaceuticals Latest Developments
Table 130. Shionogi Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Shionogi Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 132. Shionogi Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Shionogi Main Business
Table 134. Shionogi Latest Developments
Table 135. Teva Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 137. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Teva Pharmaceuticals Main Business
Table 139. Teva Pharmaceuticals Latest Developments
Table 140. RedHill Biopharma Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. RedHill Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 142. RedHill Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. RedHill Biopharma Main Business
Table 144. RedHill Biopharma Latest Developments
Table 145. Ferring Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 147. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Ferring Pharmaceuticals Main Business
Table 149. Ferring Pharmaceuticals Latest Developments
Table 150. Theravance Biopharma Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Theravance Biopharma Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 152. Theravance Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Theravance Biopharma Main Business
Table 154. Theravance Biopharma Latest Developments
Table 155. Progenity Inc. Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Progenity Inc. Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 157. Progenity Inc. Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Progenity Inc. Main Business
Table 159. Progenity Inc. Latest Developments
Table 160. Synthetic Biologics Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Synthetic Biologics Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 162. Synthetic Biologics Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Synthetic Biologics Main Business
Table 164. Synthetic Biologics Latest Developments
Table 165. Progenics Pharmaceuticals Basic Information, Chronic Constipation Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolios and Specifications
Table 167. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Progenics Pharmaceuticals Main Business
Table 169. Progenics Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Chronic Constipation Treatment Drugs
Figure 2. Chronic Constipation Treatment Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Constipation Treatment Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Chronic Constipation Treatment Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Chronic Constipation Treatment Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Chronic Constipation Treatment Drugs Sales Market Share by Country/Region (2025)
Figure 10. Chronic Constipation Treatment Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Serotonin-4 (5-Ht4) Receptor Agonist
Figure 12. Product Picture of Guanylate Cyclase-C Agonist
Figure 13. Product Picture of Laxatives
Figure 14. Product Picture of Stimulants
Figure 15. Product Picture of Others
Figure 16. Global Chronic Constipation Treatment Drugs Sales Market Share by Type in 2026
Figure 17. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2021-2026)
Figure 18. Chronic Constipation Treatment Drugs Consumed in Hospitals
Figure 19. Global Chronic Constipation Treatment Drugs Market: Hospitals (2021-2026) & (K Units)
Figure 20. Chronic Constipation Treatment Drugs Consumed in Homecare
Figure 21. Global Chronic Constipation Treatment Drugs Market: Homecare (2021-2026) & (K Units)
Figure 22. Chronic Constipation Treatment Drugs Consumed in Specialty Clinics
Figure 23. Global Chronic Constipation Treatment Drugs Market: Specialty Clinics (2021-2026) & (K Units)
Figure 24. Chronic Constipation Treatment Drugs Consumed in Others
Figure 25. Global Chronic Constipation Treatment Drugs Market: Others (2021-2026) & (K Units)
Figure 26. Global Chronic Constipation Treatment Drugs Sale Market Share by Application (2025)
Figure 27. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application in 2026
Figure 28. Chronic Constipation Treatment Drugs Sales by Company in 2026 (K Units)
Figure 29. Global Chronic Constipation Treatment Drugs Sales Market Share by Company in 2026
Figure 30. Chronic Constipation Treatment Drugs Revenue by Company in 2026 ($ millions)
Figure 31. Global Chronic Constipation Treatment Drugs Revenue Market Share by Company in 2026
Figure 32. Global Chronic Constipation Treatment Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Chronic Constipation Treatment Drugs Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 35. Americas Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 36. APAC Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 37. APAC Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 38. Europe Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 39. Europe Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 42. Americas Chronic Constipation Treatment Drugs Sales Market Share by Country in 2026
Figure 43. Americas Chronic Constipation Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 44. Americas Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 45. Americas Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 46. United States Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Chronic Constipation Treatment Drugs Sales Market Share by Region in 2026
Figure 51. APAC Chronic Constipation Treatment Drugs Revenue Market Share by Region (2021-2026)
Figure 52. APAC Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 53. APAC Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 54. China Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. India Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Chronic Constipation Treatment Drugs Sales Market Share by Country in 2026
Figure 62. Europe Chronic Constipation Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 63. Europe Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 64. Europe Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 65. Germany Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. France Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Chronic Constipation Treatment Drugs Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 73. Egypt Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Chronic Constipation Treatment Drugs in 2026
Figure 79. Manufacturing Process Analysis of Chronic Constipation Treatment Drugs
Figure 80. Industry Chain Structure of Chronic Constipation Treatment Drugs
Figure 81. Channels of Distribution
Figure 82. Global Chronic Constipation Treatment Drugs Sales Market Forecast by Region (2027-2032)
Figure 83. Global Chronic Constipation Treatment Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Chronic Constipation Treatment Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Chronic Constipation Treatment Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Chronic Constipation Treatment Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Chronic Constipation Treatment Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Chronic Constipation Treatment Drugs
Figure 2. Chronic Constipation Treatment Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Constipation Treatment Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Chronic Constipation Treatment Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Chronic Constipation Treatment Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Chronic Constipation Treatment Drugs Sales Market Share by Country/Region (2025)
Figure 10. Chronic Constipation Treatment Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Serotonin-4 (5-Ht4) Receptor Agonist
Figure 12. Product Picture of Guanylate Cyclase-C Agonist
Figure 13. Product Picture of Laxatives
Figure 14. Product Picture of Stimulants
Figure 15. Product Picture of Others
Figure 16. Global Chronic Constipation Treatment Drugs Sales Market Share by Type in 2026
Figure 17. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2021-2026)
Figure 18. Chronic Constipation Treatment Drugs Consumed in Hospitals
Figure 19. Global Chronic Constipation Treatment Drugs Market: Hospitals (2021-2026) & (K Units)
Figure 20. Chronic Constipation Treatment Drugs Consumed in Homecare
Figure 21. Global Chronic Constipation Treatment Drugs Market: Homecare (2021-2026) & (K Units)
Figure 22. Chronic Constipation Treatment Drugs Consumed in Specialty Clinics
Figure 23. Global Chronic Constipation Treatment Drugs Market: Specialty Clinics (2021-2026) & (K Units)
Figure 24. Chronic Constipation Treatment Drugs Consumed in Others
Figure 25. Global Chronic Constipation Treatment Drugs Market: Others (2021-2026) & (K Units)
Figure 26. Global Chronic Constipation Treatment Drugs Sale Market Share by Application (2025)
Figure 27. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application in 2026
Figure 28. Chronic Constipation Treatment Drugs Sales by Company in 2026 (K Units)
Figure 29. Global Chronic Constipation Treatment Drugs Sales Market Share by Company in 2026
Figure 30. Chronic Constipation Treatment Drugs Revenue by Company in 2026 ($ millions)
Figure 31. Global Chronic Constipation Treatment Drugs Revenue Market Share by Company in 2026
Figure 32. Global Chronic Constipation Treatment Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Chronic Constipation Treatment Drugs Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 35. Americas Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 36. APAC Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 37. APAC Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 38. Europe Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 39. Europe Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Chronic Constipation Treatment Drugs Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Chronic Constipation Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 42. Americas Chronic Constipation Treatment Drugs Sales Market Share by Country in 2026
Figure 43. Americas Chronic Constipation Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 44. Americas Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 45. Americas Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 46. United States Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Chronic Constipation Treatment Drugs Sales Market Share by Region in 2026
Figure 51. APAC Chronic Constipation Treatment Drugs Revenue Market Share by Region (2021-2026)
Figure 52. APAC Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 53. APAC Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 54. China Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. India Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Chronic Constipation Treatment Drugs Sales Market Share by Country in 2026
Figure 62. Europe Chronic Constipation Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 63. Europe Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 64. Europe Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 65. Germany Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. France Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Chronic Constipation Treatment Drugs Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Chronic Constipation Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Chronic Constipation Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 73. Egypt Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Chronic Constipation Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Chronic Constipation Treatment Drugs in 2026
Figure 79. Manufacturing Process Analysis of Chronic Constipation Treatment Drugs
Figure 80. Industry Chain Structure of Chronic Constipation Treatment Drugs
Figure 81. Channels of Distribution
Figure 82. Global Chronic Constipation Treatment Drugs Sales Market Forecast by Region (2027-2032)
Figure 83. Global Chronic Constipation Treatment Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Chronic Constipation Treatment Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Chronic Constipation Treatment Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Chronic Constipation Treatment Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Chronic Constipation Treatment Drugs Revenue Market Share Forecast by Application (2027-2032)
